Limiting how pharmaceutical sales representatives market their products to physicians changes the doctors’ drug prescribing behaviors, according to new research. A team, led by the University of California, Los Angeles’ Ian Larkin and Carnegie Mellon University’s George Loewenstein, examined restrictions 19 academic medical centers (AMCs) in five U.S. states placed on pharmaceutical representatives’ visits to… Continue reading The Link Between Doctors and Drug Sales Representatives